Article Details

Akebia Therapeutics Inc (NASDAQ:AKBA) Receives Consensus Rating of "Hold" from Brokerages

Retrieved on: 2020-09-01 18:28:06

Tags for this article:

Click the tags to see associated articles and topics

Akebia Therapeutics Inc (NASDAQ:AKBA) Receives Consensus Rating of "Hold" from Brokerages. View article details on HISWAI:

Excerpt

<div><b>Two Sigma Investments</b> LP now owns 19,827 shares of the biopharmaceutical company's stock valued at $150,000 after purchasing an additional 1,777 ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up